 | 6ML | Name: | oxygen-damaged SF4 | Formula: | Fe4 O2 S4 | SMILES: | S.O1[Fe]O[Fe]2S[Fe](S[Fe]1)S2 | InChi: | InChI=1S/4Fe.2O.H2S.3S/h | Definition date: | 2016-05-09 | Last modified: | 2024-09-27 | Release date: | 2017-03-22 |
|
 | L7S | Name: | 3-[(3R)-1-ethyl-2,5-dioxopyrrolidin-3-yl]benzamide | Formula: | C13 H14 N2 O3 | SMILES: | O=C2N(C(=O)CC2c1cccc(C(=O)N)c1)CC | InChi: | InChI=1S/C13H14N2O3/c1-2-15-11(16)7-10(13(15)18)8-4-3-5-9(6-8)12(14)17/h3-6,10H,2,7H2,1H3,(H2,14,17)/t10-/m1/s1 | Definition date: | 2014-07-02 | Last modified: | 2024-09-27 | Release date: | 2015-03-04 | Identifier: | 3-[(3R)-1-ethyl-2,5-dioxopyrrolidin-3-yl]benzamide |
|
 | L7U | Name: | ~{N}-[2-[2-(dimethylamino)ethyldisulfanyl]ethyl]-1-[(2~{R})-2-(6-methoxynaphthalen-2-yl)propanoyl]piperidine-4-carboxamide | Formula: | C26 H37 N3 O3 S2 | SMILES: | COc1ccc2cc(ccc2c1)[CH](C)C(=O)N3CCC(CC3)C(=O)NCCSSCCN(C)C | InChi: | InChI=1S/C26H37N3O3S2/c1-19(21-5-6-23-18-24(32-4)8-7-22(23)17-21)26(31)29-12-9-20(10-13-29)25(30)27-11-15-33-34-16-14-28(2)3/h5-8,17-20H,9-16H2,1-4H3,(H,27,30)/t19-/m1/s1 | Definition date: | 2022-06-20 | Last modified: | 2024-09-27 | Release date: | 2023-04-26 | Identifier: | ~{N}-[2-[2-(dimethylamino)ethyldisulfanyl]ethyl]-1-[(2~{R})-2-(6-methoxynaphthalen-2-yl)propanoyl]piperidine-4-carboxamide |
|
 | 6N5 | Name: | ~{N}-[(2~{S})-1-[[(2~{S})-3-(4-methoxyphenyl)-1-[[(2~{S},3~{S},4~{R})-4-methyl-3,5-bis(oxidanyl)-1-phenyl-pentan-2-yl]amino]-1-oxidanylidene-propan-2-yl]amino]-1-oxidanylidene-propan-2-yl]-1-methyl-5~{H}-indene-2-carboxamide | Formula: | C36 H43 N3 O6 | SMILES: | COc1ccc(C[CH](NC(=O)[CH](C)NC(=O)C2=CC3=CCC=CC3=C2C)C(=O)N[CH](Cc4ccccc4)[CH](O)[CH](C)CO)cc1 | InChi: | InChI=1S/C36H43N3O6/c1-22(21-40)33(41)31(18-25-10-6-5-7-11-25)38-36(44)32(19-26-14-16-28(45-4)17-15-26)39-34(42)24(3)37-35(43)30-20-27-12-8-9-13-29(27)23(30)2/h5-7,9-17,20,22,24,31-33,40-41H,8,18-19,21H2,1-4H3,(H,37,43)(H,38,44)(H,39,42)/t22-,24+,31+,32+,33+/m1/s1 | Definition date: | 2016-05-30 | Last modified: | 2024-09-27 | Release date: | 2016-11-09 | Identifier: | ~{N}-[(2~{S})-1-[[(2~{S})-3-(4-methoxyphenyl)-1-[[(2~{S},3~{S},4~{R})-4-methyl-3,5-bis(oxidanyl)-1-phenyl-pentan-2-yl]amino]-1-oxidanylidene-propan-2-yl]amino]-1-oxidanylidene-propan-2-yl]-1-methyl-5~{H}-indene-2-carboxamide |
|
 | L8F | Name: | N-(2-{7-[(4-acetylpiperazin-1-yl)methyl]-1H-indol-3-yl}ethyl)acetamide | Formula: | C19 H26 N4 O2 | SMILES: | CC(=O)NCCc1c[NH]c2c(CN3CCN(CC3)C(C)=O)cccc21 | InChi: | InChI=1S/C19H26N4O2/c1-14(24)20-7-6-16-12-21-19-17(4-3-5-18(16)19)13-22-8-10-23(11-9-22)15(2)25/h3-5,12,21H,6-11,13H2,1-2H3,(H,20,24) | Definition date: | 2023-08-15 | Last modified: | 2024-09-27 | Release date: | 2023-11-08 | Identifier: | N-(2-{7-[(4-acetylpiperazin-1-yl)methyl]-1H-indol-3-yl}ethyl)acetamide |
|
 | L8O | Name: | 1-[(4R)-4-(3-methylphenyl)-3,4-dihydroisoquinolin-2(1H)-yl]ethan-1-one | Formula: | C18 H19 N O | SMILES: | Cc1cccc(c1)C1CN(Cc2ccccc21)C(C)=O | InChi: | InChI=1S/C18H19NO/c1-13-6-5-8-15(10-13)18-12-19(14(2)20)11-16-7-3-4-9-17(16)18/h3-10,18H,11-12H2,1-2H3/t18-/m1/s1 | Definition date: | 2023-08-15 | Last modified: | 2024-09-27 | Release date: | 2023-11-08 | Identifier: | 1-[(4R)-4-(3-methylphenyl)-3,4-dihydroisoquinolin-2(1H)-yl]ethan-1-one |
|
 | 6NV | Name: | ~{N}-[(2~{R})-1-[[(2~{S})-3-(4-methoxyphenyl)-1-[[(2~{S},3~{S},4~{R})-4-methyl-3,5-bis(oxidanyl)-1-phenyl-pentan-2-yl]amino]-1-oxidanylidene-propan-2-yl]amino]-1-oxidanylidene-propan-2-yl]-1-methyl-5~{H}-indene-2-carboxamide | Formula: | C36 H43 N3 O6 | SMILES: | COc1ccc(C[CH](NC(=O)[CH](C)NC(=O)C2=CC3=CCC=CC3=C2C)C(=O)N[CH](Cc4ccccc4)[CH](O)[CH](C)CO)cc1 | InChi: | InChI=1S/C36H43N3O6/c1-22(21-40)33(41)31(18-25-10-6-5-7-11-25)38-36(44)32(19-26-14-16-28(45-4)17-15-26)39-34(42)24(3)37-35(43)30-20-27-12-8-9-13-29(27)23(30)2/h5-7,9-17,20,22,24,31-33,40-41H,8,18-19,21H2,1-4H3,(H,37,43)(H,38,44)(H,39,42)/t22-,24-,31+,32+,33+/m1/s1 | Definition date: | 2016-05-30 | Last modified: | 2024-09-27 | Release date: | 2016-11-09 | Identifier: | ~{N}-[(2~{R})-1-[[(2~{S})-3-(4-methoxyphenyl)-1-[[(2~{S},3~{S},4~{R})-4-methyl-3,5-bis(oxidanyl)-1-phenyl-pentan-2-yl]amino]-1-oxidanylidene-propan-2-yl]amino]-1-oxidanylidene-propan-2-yl]-1-methyl-5~{H}-indene-2-carboxamide |
|
 | L8X | Name: | methyl (1S,3R)-2-(chloroacetyl)-1-[4-(methoxycarbonyl)phenyl]-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate | Formula: | C23 H21 Cl N2 O5 | SMILES: | O=C(OC)c1ccc(cc1)C1c2[NH]c3ccccc3c2CC(C(=O)OC)N1C(=O)CCl | InChi: | InChI=1S/C23H21ClN2O5/c1-30-22(28)14-9-7-13(8-10-14)21-20-16(15-5-3-4-6-17(15)25-20)11-18(23(29)31-2)26(21)19(27)12-24/h3-10,18,21,25H,11-12H2,1-2H3/t18-,21+/m1/s1 | Definition date: | 2022-03-01 | Last modified: | 2024-09-27 | Release date: | 2022-12-07 | Identifier: | methyl (1S,3R)-2-(chloroacetyl)-1-[4-(methoxycarbonyl)phenyl]-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate |
|
 | L9C | Name: | 2-chloro-N-(3-chloro-4-methoxyphenyl)-N-[(1R)-2-oxo-2-[(2-phenylethyl)amino]-1-(thiophen-2-yl)ethyl]acetamide | Formula: | C23 H22 Cl2 N2 O3 S | SMILES: | O=C(CCl)N(C(c1cccs1)C(=O)NCCc1ccccc1)c1ccc(OC)c(Cl)c1 | InChi: | InChI=1S/C23H22Cl2N2O3S/c1-30-19-10-9-17(14-18(19)25)27(21(28)15-24)22(20-8-5-13-31-20)23(29)26-12-11-16-6-3-2-4-7-16/h2-10,13-14,22H,11-12,15H2,1H3,(H,26,29)/t22-/m0/s1 | Definition date: | 2022-03-01 | Last modified: | 2024-09-27 | Release date: | 2022-12-07 | Identifier: | 2-chloro-N-(3-chloro-4-methoxyphenyl)-N-[(1R)-2-oxo-2-[(2-phenylethyl)amino]-1-(thiophen-2-yl)ethyl]acetamide |
|
 | L9U | Name: | 2-bromo-N-[(thiophen-2-yl)methyl]acetamide | Formula: | C7 H8 Br N O S | SMILES: | O=C(NCc1cccs1)CBr | InChi: | InChI=1S/C7H8BrNOS/c8-4-7(10)9-5-6-2-1-3-11-6/h1-3H,4-5H2,(H,9,10) | Definition date: | 2022-03-01 | Last modified: | 2024-09-27 | Release date: | 2022-12-07 | Identifier: | 2-bromo-N-[(thiophen-2-yl)methyl]acetamide |
|
 | 88T | Name: | (1~{R},4~{R},11~{S},14~{S},19~{Z})-19-[2-[2,5-bis(oxidanylidene)pyrrolidin-1-yl]ethylimino]-7,8,17,18-tetraoxa-1,4,11,14-tetrazatricyclo[12.6.2.2^{4,11}]tetracosane-6,9,16-trione | Formula: | C22 H32 N6 O9 | SMILES: | O=C1C[N]2CC[N](CC[N]3CC[N](CC2)CC(=O)OOC(C3)=NCCN4C(=O)CCC4=O)CC(=O)OO1 | InChi: | InChI=1S/C22H32N6O9/c29-18-1-2-19(30)28(18)4-3-23-17-13-24-5-7-25(14-20(31)35-34-17)9-11-27-12-10-26(8-6-24)15-21(32)36-37-22(33)16-27/h1-16H2/b23-17- | Definition date: | 2021-10-07 | Last modified: | 2024-09-27 | Release date: | 2022-08-24 | Identifier: | (1~{R},4~{R},11~{S},14~{S},19~{Z})-19-[2-[2,5-bis(oxidanylidene)pyrrolidin-1-yl]ethylimino]-7,8,17,18-tetraoxa-1,4,11,14-tetrazatricyclo[12.6.2.2^{4,11}]tetracosane-6,9,16-trione |
|
 | L9Z | Name: | (1~{S},3~{S},4~{S},5~{R})-3-(aminomethyl)-3,4,5-tris(hydroxyl)cyclohexane-1-carboxylic acid | Formula: | C8 H15 N O5 | SMILES: | NC[C]1(O)C[CH](C[CH](O)[CH]1O)C(O)=O | InChi: | InChI=1S/C8H15NO5/c9-3-8(14)2-4(7(12)13)1-5(10)6(8)11/h4-6,10-11,14H,1-3,9H2,(H,12,13)/t4-,5+,6-,8-/m0/s1 | Definition date: | 2019-08-01 | Last modified: | 2024-09-27 | Release date: | 2020-04-15 | Identifier: | (1~{S},3~{S},4~{S},5~{R})-3-(aminomethyl)-3,4,5-tris(oxidanyl)cyclohexane-1-carboxylic acid |
|
 | LA2 | Name: | N~6~-[(6R)-6,8-disulfanyloctanoyl]-L-lysine | Formula: | C14 H28 N2 O3 S2 | SMILES: | O=C(O)C(N)CCCCNC(=O)CCCCC(S)CCS | InChi: | InChI=1S/C14H28N2O3S2/c15-12(14(18)19)6-3-4-9-16-13(17)7-2-1-5-11(21)8-10-20/h11-12,20-21H,1-10,15H2,(H,16,17)(H,18,19)/t11-,12+/m1/s1 | Synonyms: | lipoyllysine | Definition date: | 2008-04-16 | Last modified: | 2024-09-27 | Identifier: | N~6~-[(6R)-6,8-disulfanyloctanoyl]-L-lysine |
|
 | LAC | Name: | LACTIC ACID | Formula: | C3 H6 O3 | SMILES: | O=C(O)C(O)C | InChi: | InChI=1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/t2-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (2R)-2-hydroxypropanoic acid |
|
 | LAF | Name: | 5-FLUOROLEVULINIC ACID | Formula: | C5 H7 F O3 | SMILES: | FCC(=O)CCC(=O)O | InChi: | InChI=1S/C5H7FO3/c6-3-4(7)1-2-5(8)9/h1-3H2,(H,8,9) | Definition date: | 2002-05-21 | Last modified: | 2024-09-27 | Identifier: | 5-fluoro-4-oxopentanoic acid |
|
 | 89B | Name: | N-[(2S)-3-(4-fluorophenyl)-1-oxidanylidene-1-[[(2R,3S)-3-oxidanyl-4-oxidanylidene-1-[(3S)-2-oxidanylidenepiperidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-1-benzofuran-2-carboxamide | Formula: | C34 H35 F N4 O6 | SMILES: | O[CH]([CH](C[CH]1CCCNC1=O)NC(=O)[CH](Cc2ccc(F)cc2)NC(=O)c3oc4ccccc4c3)C(=O)NCc5ccccc5 | InChi: | InChI=1S/C34H35FN4O6/c35-25-14-12-21(13-15-25)17-27(39-33(43)29-19-23-9-4-5-11-28(23)45-29)32(42)38-26(18-24-10-6-16-36-31(24)41)30(40)34(44)37-20-22-7-2-1-3-8-22/h1-5,7-9,11-15,19,24,26-27,30,40H,6,10,16-18,20H2,(H,36,41)(H,37,44)(H,38,42)(H,39,43)/t24-,26+,27-,30-/m0/s1 | Definition date: | 2021-11-30 | Last modified: | 2024-09-27 | Release date: | 2023-05-31 | Identifier: | ~{N}-[(2~{S})-3-(4-fluorophenyl)-1-oxidanylidene-1-[[(2~{R},3~{S})-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepiperidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-1-benzofuran-2-carboxamide |
|
 | LAL | Name: | N,N-DIMETHYL-L-ALANINE | Formula: | C5 H11 N O2 | SMILES: | O=C(O)C(N(C)C)C | InChi: | InChI=1S/C5H11NO2/c1-4(5(7)8)6(2)3/h4H,1-3H3,(H,7,8)/t4-/m0/s1 | Definition date: | 2003-10-01 | Last modified: | 2024-09-27 | Identifier: | N,N-dimethyl-L-alanine |
|
 | 89K | Name: | N-[(2S)-3-cyclohexyl-1-oxidanylidene-1-[[(2S,3S)-3-oxidanyl-4-oxidanylidene-1-[(3S)-2-oxidanylidenepiperidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-1-benzofuran-2-carboxamide | Formula: | C34 H42 N4 O6 | SMILES: | O[CH]([CH](C[CH]1CCCNC1=O)NC(=O)[CH](CC2CCCCC2)NC(=O)c3oc4ccccc4c3)C(=O)NCc5ccccc5 | InChi: | InChI=1S/C34H42N4O6/c39-30(34(43)36-21-23-12-5-2-6-13-23)26(19-25-15-9-17-35-31(25)40)37-32(41)27(18-22-10-3-1-4-11-22)38-33(42)29-20-24-14-7-8-16-28(24)44-29/h2,5-8,12-14,16,20,22,25-27,30,39H,1,3-4,9-11,15,17-19,21H2,(H,35,40)(H,36,43)(H,37,41)(H,38,42)/t25-,26-,27-,30-/m0/s1 | Definition date: | 2021-11-30 | Last modified: | 2024-09-27 | Release date: | 2023-05-31 | Identifier: | ~{N}-[(2~{S})-3-cyclohexyl-1-oxidanylidene-1-[[(2~{S},3~{S})-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepiperidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-1-benzofuran-2-carboxamide |
|
 | 89N | Name: | (2E)-but-2-ene-1,4-diol | Formula: | C4 H8 O2 | SMILES: | OCC=CCO | InChi: | InChI=1S/C4H8O2/c5-3-1-2-4-6/h1-2,5-6H,3-4H2/b2-1+ | Definition date: | 2021-09-14 | Last modified: | 2024-09-27 | Release date: | 2021-11-03 | Identifier: | (2E)-but-2-ene-1,4-diol |
|
 | LAS | Name: | N-acetyl-S-({(2R,3S,4R)-3-hydroxy-2-[(1S)-1-hydroxy-2-methylpropyl]-4-methyl-5-oxopyrrolidin-2-yl}carbonyl)cysteine | Formula: | C15 H24 N2 O7 S | SMILES: | O=C1NC(C(=O)SCC(C(=O)O)NC(=O)C)(C(O)C1C)C(O)C(C)C | InChi: | InChI=1S/C15H24N2O7S/c1-6(2)10(19)15(11(20)7(3)12(21)17-15)14(24)25-5-9(13(22)23)16-8(4)18/h6-7,9-11,19-20H,5H2,1-4H3,(H,16,18)(H,17,21)(H,22,23)/t7-,9?,10+,11+,15-/m1/s1 | Synonyms: | LACTACYSTIN | Definition date: | 2008-07-10 | Last modified: | 2024-09-27 | Identifier: | N-acetyl-S-({(2R,3S,4R)-3-hydroxy-2-[(1S)-1-hydroxy-2-methylpropyl]-4-methyl-5-oxopyrrolidin-2-yl}carbonyl)cysteine |
|
 | LAV | Name: | N-[(2S)-2-amino-4-methylpentyl]-L-valine | Formula: | C11 H24 N2 O2 | SMILES: | O=C(O)C(NCC(N)CC(C)C)C(C)C | InChi: | InChI=1S/C11H24N2O2/c1-7(2)5-9(12)6-13-10(8(3)4)11(14)15/h7-10,13H,5-6,12H2,1-4H3,(H,14,15)/t9-,10-/m0/s1 | Definition date: | 2010-10-28 | Last modified: | 2024-09-27 | Identifier: | N-[(2S)-2-amino-4-methylpentyl]-L-valine |
|
 | LAY | Name: | N-acetyl-L-leucine | Formula: | C8 H15 N O3 | SMILES: | O=C(NC(C(=O)O)CC(C)C)C | InChi: | InChI=1S/C8H15NO3/c1-5(2)4-7(8(11)12)9-6(3)10/h5,7H,4H2,1-3H3,(H,9,10)(H,11,12)/t7-/m0/s1 | Definition date: | 2015-01-22 | Last modified: | 2024-09-27 | Release date: | 2016-01-27 | Identifier: | N-acetyl-L-leucine |
|
 | LBF | Name: | Leptomycin B | Formula: | C33 H48 O6 | SMILES: | O=C(O)C=C(/C)CC(C)C(O)C(C(=O)C(/C=C(/C=C/CC(/C=C(C=CC1OC(=O)C=CC1C)CC)C)C)C)C | InChi: | InChI=1S/C33H48O6/c1-9-28(14-15-29-24(5)13-16-31(36)39-29)19-22(3)12-10-11-21(2)17-25(6)32(37)27(8)33(38)26(7)18-23(4)20-30(34)35/h10-11,13-17,19-20,22,24-27,29,33,38H,9,12,18H2,1-8H3,(H,34,35)/b11-10+,15-14+,21-17+,23-20+,28-19-/t22-,24+,25-,26+,27-,29+,33-/m1/s1 | Definition date: | 2012-10-11 | Last modified: | 2024-09-27 | Release date: | 2013-01-04 | Identifier: | (2E,5S,6R,7S,9R,10E,12E,15R,16Z,18E)-17-ethyl-6-hydroxy-3,5,7,9,11,15-hexamethyl-19-[(2S,3S)-3-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl]-8-oxononadeca-2,10,12,16,18-pentaenoic acid |
|
 | LBI | Name: | 4-methoxy-1H-indole-2-carbaldehyde | Formula: | C10 H9 N O2 | SMILES: | COc1cccc2[NH]c(cc21)C=O | InChi: | InChI=1S/C10H9NO2/c1-13-10-4-2-3-9-8(10)5-7(6-12)11-9/h2-6,11H,1H3 | Definition date: | 2022-03-01 | Last modified: | 2024-09-27 | Release date: | 2022-12-07 | Identifier: | 4-methoxy-1H-indole-2-carbaldehyde |
|
 | 8AM | Name: | N-[(3R,4R)-4-fluoro-1-{6-[(3-methoxy-1-methyl-1H-pyrazol-4-yl)amino]-9-(propan-2-yl)-9H-purin-2-yl}pyrrolidin-3-yl]propanamide | Formula: | C20 H28 F N9 O2 | SMILES: | C1C(NC(=O)CC)C(CN1c3nc(Nc2cn(C)nc2OC)c4c(n3)n(cn4)C(C)C)F | InChi: | InChI=1S/C20H28FN9O2/c1-6-15(31)23-13-9-29(7-12(13)21)20-25-17(24-14-8-28(4)27-19(14)32-5)16-18(26-20)30(10-22-16)11(2)3/h8,10-13H,6-7,9H2,1-5H3,(H,23,31)(H,24,25,26)/t12-,13-/m1/s1 | Definition date: | 2017-01-17 | Last modified: | 2024-09-27 | Release date: | 2017-03-22 | Identifier: | N-[(3R,4R)-4-fluoro-1-{6-[(3-methoxy-1-methyl-1H-pyrazol-4-yl)amino]-9-(propan-2-yl)-9H-purin-2-yl}pyrrolidin-3-yl]propanamide |
|